Inhibition of Human Immunodeficiency Virus Type 1 Replication In Vitro by the Bisheteroarylpiperzine Atevirdine (U-87201E) in Combination with Zidovudine or Didanosine
Data up to Jan 2025
Total Citations Per Year
Abstract
References (35)
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
1984 • 6,841 citations
Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor
1992 • 1,887 citations
HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
1989 • 1,574 citations
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
1990 • 749 citations
Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor
1990 • 740 citations
Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.
1991 • 398 citations
Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors
1991 • 366 citations
Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group
1993 • 296 citations
Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
1991 • 289 citations
Ribavirin Antagonizes the Effect of Azidothymidine on HIV Replication
1987 • 282 citations
Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon
1987 • 237 citations
Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories
1992 • 229 citations
Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus.
1990 • 204 citations
Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy
1989 • 181 citations
Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy
1990 • 180 citations
Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro
1987 • 167 citations
A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.
1993 • 163 citations
BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine
1991 • 161 citations
Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy
1993 • 156 citations
Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant Interferon- A Inhibit Replication of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Synergistically In Vitro
1991 • 131 citations
Inhibition of Human Immunodeficiency Virus Type I (HIV-I) Replication by the Dipyridodiazepinone BI-RG-587
1991 • 112 citations
Decreased In Vitro Susceptibility to Zidovudine of HIV Isolates Obtained from Patients with AIDS
1990 • 100 citations
Synergistic activity of granulocyte-macrophage colony-stimulating factor and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro
1987 • 87 citations
Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells
1991 • 82 citations
Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine
1989 • 69 citations
Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet
1989 • 66 citations
Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro
1992 • 63 citations
The binding of a novel bisheteroarylpiperazine mediates inhibition of human immunodeficiency virus type 1 reverse transcriptase.
1992 • 62 citations
Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitors
1992 • 61 citations
Synergistic Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Replication In Vitro by Recombinant Soluble CD4 and 3'-Azido-3'-Deoxythymidine
1989 • 60 citations
pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo
1993 • 59 citations
Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine
1991 • 44 citations
Combined Treatment of Symptomatic Human Immunodeficiency Virus Type 1 Infection with Native Interferon- and Zidovudine
1991 • 39 citations
COMBO: A New Approach to the Analysis of Drug Combinations in Vitroa
1990 • 16 citations
Differential Alteration of the Anti-HIV-1 Effect of Phosphorothioate Oligonucleotide S-dC28 by AZT, Interferon-Alpha, and Dextran Sulfate
1991 • 8 citations